Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (201-210 of 238) with videos related to

Pageof 24
Sort By:
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 1, 2017
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis CohortElena López-Isac, Lara Bossini-Castillo, Ana B Palma, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
The Journal of Rheumatology|February 19, 2013
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trialEmily W Hung, Maureen D Mayes, Roozbeh Sharif, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profileBrian Skaug, Dinesh Khanna, William R Swindell, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2014
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locusElena López-Isac, Lara Bossini-Castillo, Sandra G Guerra, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathwayElena López-Isac, Diana Campillo-Davo, Lara Bossini-Castillo, et al.
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
Pageof 24

Showing results (201-210 of 238) with videos related to

Sort By:
Pageof 24
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 1, 2017
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis CohortElena López-Isac, Lara Bossini-Castillo, Ana B Palma, et al.
The Lancet. Rheumatology|April 18, 2026
Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association studyInmaculada Rodriguez-Martin, Martin Kerick, Carlos Rangel-Peláez, et al.
The Journal of Rheumatology|February 19, 2013
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trialEmily W Hung, Maureen D Mayes, Roozbeh Sharif, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profileBrian Skaug, Dinesh Khanna, William R Swindell, et al.
Rheumatology (Oxford, England)|April 20, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilizationSarah Luebker, Tracy M Frech, Shervin Assassi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2014
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locusElena López-Isac, Lara Bossini-Castillo, Sandra G Guerra, et al.
Annals of the Rheumatic Diseases|September 5, 2015
Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathwayElena López-Isac, Diana Campillo-Davo, Lara Bossini-Castillo, et al.
Annals of the American Thoracic Society|April 10, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United StatesYiming Luo, Shervin Assassi, Maureen D Mayes, et al.
The Journal of Rheumatology|January 15, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic SclerosisJeong Min Yu, John M VanBuren, Angela Child, et al.
Pageof 24